2.5.5.2: Angiotensin-II receptor antagonists

Part of chapter 2 Cardiovascular System, section 2.5 Hypertension and heart failure

High-level prescribing trends for Angiotensin-II receptor antagonists (BNF section 2.5.5.2) across Dr MLR Siddiqui's Practice for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Azilsartan medoxomil (0205052AD)
Candesartan cilexetil (0205052C0)
Eprosartan (0205052W0)
Irbesartan (0205052I0)
Irbesartan with diuretic (0205052A0)
Losartan potassium (0205052N0)
Losartan potassium with diuretic (0205052P0)
Olmesartan medoxomil (0205052B0)
Olmesartan medoxomil/amlodipine (0205052AB)
Olmesartan medoxomil/amlodipine/hydrochlorothiazide (0205052AC)
Olmesartan medoxomil/hydrochlorothiazide (0205052Y0)
Sacubitril/valsartan (0205052AE)
Telmisartan (0205052Q0)
Telmisartan with diuretic (0205052R0)
Valsartan (0205052V0)
Valsartan with diuretic (0205052X0)
Feedback